Barron's Interview Joseph McNay Of Essex Investment Management
8900 views
Rate Now: 1 2 3 4

average rating: 2.50 / 2 ratings
Created by barrons2
DESCRIPTION:

Date updated:02-02-2008

Joseph McNay has made a lot of people and institutions wealthy in the 40-plus years he's been playing the investment trade. He manages more than $3 billion at Essex Investment Management in Boston, a firm he founded, including its flagship long-short fund and a natural-resources fund. -- Sandra Ward

symbol name last price % change open
  • +
  • GLD
    Spdr Gold Shares
  • $114.29
  • +1.20%
  • $114.67

Q: When you talk about gold, should people be thinking in terms of the mining companies or bullion? A: Both. The metal has outperformed the mining companies in the last three years, but that relationship is in the process of switching and mining companies will be the best investment. But they will both be good investments. There are two ETFs that are convenient for a lot of people: streetTracks Gold Trust [ticker: GLD] tracks the gold and Market Vector Gold Miners [GDX] tracks the mining companies.

People owning GLD also tend to own: ANVAYEAZOBBYBPZCOHCTRN

TheStreet.com Rating: No Rating What is this?

  • +
  • GDX
    Mkt Vect Gold Mnr
  • $51.68
  • 0.00%
  • $N/A

Q: When you talk about gold, should people be thinking in terms of the mining companies or bullion? A: Both. The metal has outperformed the mining companies in the last three years, but that relationship is in the process of switching and mining companies will be the best investment. But they will both be good investments. There are two ETFs that are convenient for a lot of people: streetTracks Gold Trust [ticker: GLD] tracks the gold and Market Vector Gold Miners [GDX] tracks the mining companies.

People owning GDX also tend to own: ATVICCJCELGCRZODSXDVNEMC

TheStreet.com Rating: No Rating What is this?

  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

Q: Can you be more specific? A: The biotech companies have the new products and are a way to participate in this industry. They are like buying the drug companies back in 1960. My three favorites are Genentech [DNA] and Gilead Sciences [GILD] and Celgene [CELG]. They all have very good products and great growth rates, and no risk, from my point of view, to an economic slowdown and a falling dollar.

People owning DNA also tend to own: AAPLDSCMGOOGXOMDWELXGLW

TheStreet.com Rating: No Rating What is this?

  • +
  • GILD
    Gilead Sciences
  • $47.01
  • +1.34%
  • $46.91

Q: Can you be more specific? A: The biotech companies have the new products and are a way to participate in this industry. They are like buying the drug companies back in 1960. My three favorites are Genentech [DNA] and Gilead Sciences [GILD] and Celgene [CELG]. They all have very good products and great growth rates, and no risk, from my point of view, to an economic slowdown and a falling dollar.

People owning GILD also tend to own: ACASAINVARCCAUBACCELFCX

TheStreet.com Rating: B What is this?

  • +
  • CELG
    Celgene Corporati
  • $55.65
  • +1.35%
  • $55.20

Q: Can you be more specific? A: The biotech companies have the new products and are a way to participate in this industry. They are like buying the drug companies back in 1960. My three favorites are Genentech [DNA] and Gilead Sciences [GILD] and Celgene [CELG]. They all have very good products and great growth rates, and no risk, from my point of view, to an economic slowdown and a falling dollar.

People owning CELG also tend to own: ACLALXNBMRNCVHCVSESRXGENZ

TheStreet.com Rating: B- What is this?

  • +
  • BMRN
    Biomarin Pharmace
  • $16.97
  • 0.00%
  • $17.21

Q: How about a new recommendation in that area? A: BioMarin Pharmaceuticals [BMRN] has some nice products. It is coming along with some very nice drugs to treat small patient populations, similar to Genzyme [GENZ], where there is not much competition and the drug has a limited market but is necessary for survival.

People owning BMRN also tend to own: BIOMBLDPDJOEICUFULHWCCMEMY

TheStreet.com Rating: C- What is this?

  • +
  • ISRG
    Intuitive Surgica
  • $280.80
  • +1.58%
  • $277.92

Q: What do you like among medical-device and instrument companies? A: I love Intuitive Surgical [ISRG], the leader in robotic surgery. It went up a lot, from about 105 to 350, before falling back to 254, and so it has corrected. But it has the absolute leadership position in the field and is continuing to grow very rapidly. If you have breast cancer or prostate cancer or are having a hysterectomy, you unequivocally want to go where they are using Intuitive Surgical robotic surgery because the results are much better. That's a good growth area. The stock is still kind of rich, even though it has corrected, but it has a lot of growth ahead of it.

People owning ISRG also tend to own: ABBASEINVSPGAAPLACNAMZN

TheStreet.com Rating: B What is this?

  • +
  • ALDN
    Aldn
  • $0.00
  • N/A
  • $N/A

Q: Let's turn to some emerging companies that have caught your interest. A: A company called Aladdin Knowledge Systems [ALDN] has been overlooked by a lot of people. It is an Israeli company that develops enterprise-network security software used for application access. This company has been growing earnings at 20%-plus lately. Last year, earnings rose from 93 cents a share to $1.15, and this year they are probably going to go to $1.40 a share. They had a very good quarter recently, up over 21%. It's not too expensive, selling at 20 and earning, say, $1.40 a share this year and $1.60 next year.

People owning ALDN also tend to own: ACSEFBPHXCAMTELOSELTKESLTFORTY

TheStreet.com Rating: No Rating What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...

11.24.09 | 11:36 AM
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 24, 2009 10 Terrific Dividend Stocks: This Barron’s article highlights 10 high-quality dividend-paying stocks for investors who’re ...

11.24.09 | 08:05 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...

11.23.09 | 10:34 AM
Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. OK, what would it take to make g...
11.24.09 | 18:01 PM Asked by alchemist

A. A stronger dollar, reduction in
government debt, gold backing of the
dollar.

today 's lists
Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

Biggest % Gainers

Here are some of the largest % gainers from Nov. 24, 2009. more

Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more